[Preliminary comparison of efficacy and safety of dasatinib and imatinib in newly diagnosed chronic myeloid leukemia].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Volumn 34, Issue 2, 2013, Pages 93-97

  Zhou, L ^a   Wang, Jian xiang ^b   Huang, Xiao jun ^b   Hu, Jian da ^b   Shen, Zhi xiang ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BENZAMIDE DERIVATIVE; DASATINIB; IMATINIB; PIPERAZINE DERIVATIVE; PYRIMIDINE DERIVATIVE; THIAZOLE DERIVATIVE;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MIDDLE AGED; MYELOID LEUKEMIA; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; AGED; BENZAMIDES; FEMALE; HUMANS; LEUKEMIA, MYELOID, CHRONIC-PHASE; MALE; MIDDLE AGED; PIPERAZINES; PYRIMIDINES; SURVIVAL RATE; THIAZOLES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84887159826     PISSN: 02532727     EISSN: None     Source Type: None    
DOI: None     Document Type: Article

References (0)